Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Marco Ruiz is a Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, myelodysplastic syndrome, myelofibrosis, HIV related malignancies, stem cell transplants, geriatric oncology, and palliative medicine at the Miami Cancer Institute in Miami, Florida.  He is also an experienced bone marrow transplant specialist and is active in cancer research. Growing up the son of a nurse, Dr. Ruiz knew at a young age that he wanted to pursue a career in medicine. But it was his father’s battle with cancer that sparked a passion for helping patients with the disease.

Spanish Blood Cancer Library - Novel new drugs in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) and how they work
Fármacos nuevos para la leucemiamieloideaguda (LMA) y para el síndrome mielodisplásico (MDS) y ¿Cómofuncionan?
Author
Marco A. Ruiz, MD, GRACE Faculty

GRACE sat down with Dr. Marco Ruiz to discuss information regarding novel new drugs in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) and how they work (¿Fármacos nuevos para la leucemiamieloideaguda (LMA) y para el síndrome mielodisplásico (MDS) y ¿Cómofuncionan?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Acute Myeloid Leukemia & Myelodysplastic Syndrome, (Leucemia mieloide aguda y síndrome mielodisplásico).


 

We would like to thank the following company for their support of this program:

 


 

Next Previous link

Previous PostNext Post

Related Content

Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.